Measurements of agreement | |||||
---|---|---|---|---|---|
Kappa | SE | P-value | Percentage | ||
1 | Eligibility criteria included | 0.70d | 0.18 | 0.005 | 86 |
2 | Randomization method stated | 1.00e | 0.00 | < 0.001 | 100 |
3 | Allocation concealment | 1.00e | 0.00 | < 0.001 | 100 |
4 | Groups similar at baseline | NA | - | - | 92 |
5 | Assessor blinded | Constant | - | - | 100 |
6a | Study withdrawals < 15% | 1.00e | 0.00 | < 0.001 | 100 |
6b | Adverse events reported | 1.00e | 0.00 | < 0.001 | 100 |
6c | Session attendance reported | 0.63d | 0.33 | 0.011 | 92 |
7 | Intention-to-treat analysis | Constant | - | - | 100 |
8a | Between-group primary analysis | Constant | - | - | 100 |
8b | Between-group secondary analysis | Constant | - | - | 100 |
9 | Point measures for all outcomes | Constant | - | - | 100 |
10 | Activity monitoring controls | Constant | - | - | 100 |
11 | Relative exercise intensity adjusted | Constant | - | - | 100 |
12 | Exercise energy expenditure information reported | Constant | - | - | 100 |
Total scores of intra-rater agreement | 0.78d | 0.14 | < 0.001 | 85 |